Ozempic and Wegovy linked to surprising drop in violent behavior
A Rutgers University study suggests that GLP-1 medications like Ozempic and Wegovy may reduce violent behavior by mitigating the effects of impulsivity and alcohol consumption. Researchers analyzed survey data from over 7,500 adults to identify a weaker link between these behavioral triggers and violence in current medication users.
Why it matters
This research highlights potential secondary public health benefits of popular weight-loss drugs, suggesting they could have implications for public safety beyond metabolic health.
Popular GLP-1 medications such as Ozempic and Wegovy are best known for helping people lose weight and manage diabetes. New research from Rutgers University suggests these drugs may also be linked to changes in behaviors associated with violence.
The article reports on scientific findings from a university study without injecting editorial opinion or political framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in